Moderna is a Massachusetts-based biotechnology company that researches and develops messenger mRNA therapeutics to treat diseases such as cardiovascular and auto-immune.
Business Model:
Revenue: $21.4B
Employees: 1,001-5,000
Address: 200 Technology Square
City: Cambridge
State: MA
Zip: 02139
Country: US
Moderna is a Massachusetts-based biotechnology company that researches and develops messenger mRNA therapeutics to treat diseases such as cardiovascular and auto-immune.
Contact Phone:
+16177146500
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
12/6/2018
IPO Valuation:
$8B
Ticker Symbol:
MRNA
IPO Price:
$23/share
Amount Raised:
$604M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2014 | Onkaido Therapeutics | Venture Round | 0 |
1/2023 | Metagenomi | Series B | 0 |
1/2022 | Metagenomi | Series B | 0 |
1/2022 | Metagenomi | Series B | 0 |
1/2014 | Onkaido Therapeutics | Venture Round | 0 |
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|